First Time Loading...

Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390

Watchlist Manager
Guizhou Xinbang Pharmaceutical Co Ltd Logo
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Watchlist
Price: 3.83 CNY -1.29% Market Closed
Updated: May 21, 2024

Guizhou Xinbang Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guizhou Xinbang Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Interest Income Expense
-¥12.1m
CAGR 3-Years
54%
CAGR 5-Years
37%
CAGR 10-Years
-1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
¥1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
¥134.5m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
¥429.9m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
30%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
¥1.1B
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
37%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Interest Income Expense
-¥20.1m
CAGR 3-Years
-107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guizhou Xinbang Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-12.1m CNY

Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Interest Income Expense amounts to -12.1m CNY.

What is Guizhou Xinbang Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-1%

The average annual Interest Income Expense growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been 54% over the past three years , 37% over the past five years , and -1% over the past ten years .